French Competition Probe Targets Price Setting, Distribution, And Generic Rebates

Four years after its last inquiry into competition in the pharmaceutical market, the French competition authority is to look into how the prices of medicines are set, the level of rebates in the generics market, and the “economic and competitive balance of the pharmaceutical distribution chain.”